BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 5, 2001
View Archived Issues
Organogenesis and Biomet establish product development agreement
Read More
Immune Response updates Remune development program
Read More
OraPharma commences phase I trial of OC-1012 for mucositis prevention
Read More
SBIR grant received by Acorda for spinal cord injury regeneration research
Read More
MediGene signs agreement with Memorial Sloan-Kettering for HSV in cancer treatment
Read More
GE Medical Systems and GSK collaborate on molecular imaging technologies
Read More
Single and multiple oral doses of SPP-100 provide sustained RAS inhibition in humans
Read More
RSD-1235 terminates atrial fibrillation in dogs
Read More
ACS news: preparation of ABT-839 for toxicology and clinical studies
Read More
MMP-1-sparing matrix metalloproteinase inhibitors possessing antiangiogenic/antitumor properties
Read More
Preclinical and phase I/II study findings on VEGF165 gene therapy reported at ESC congress
Read More
Medivir and Chiron establish collaboration for novel HCV drugs
Read More
Efficacy of antisense therapy with AVI-4126 demonstrated in preclinical testing
Read More
New DIC therapeutic scheduled for filing soon by Japanese company
Read More
RegeneRx and UT Southwestern establish research agreement for TB4
Read More
Role of proteasome and proteasome inhibitors in vascular restenosis
Read More
Novel therapeutic approach to autoimmune diseases identified by ZymoGenetics and Serono
Read More
DuPont presents data on vitronectin receptor antagonist-based tumor imaging agents
Read More
FDA issues complete response letter for FluMist BLA
Read More
Class III/IV/Ib antiarrhythmic properties also seen for EGIS-7229 in human myocardium
Read More
FDA grants orphan drug status for new Genasense indications
Read More
Preclinical studies continue to define spectrum, susceptibility criteria of GAR-936
Read More
Karo Bio and AHP to develop new atherosclerosis drug
Read More
Novel treatments for rheumatoid arthritis and other autoimmune diseases presented by Dainippon
Read More
iGluR5-selective glutamate receptor antagonists useful for migraine Rx
Read More
Potential analgesic agents claimed by AstraZeneca in recent patents
Read More
Antiviral quinolones under study at GSK
Read More